Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31false22023-04-01falseNo description of principal activity2falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10187972 2023-04-01 2024-03-31 10187972 2022-04-01 2023-03-31 10187972 2024-03-31 10187972 2023-03-31 10187972 c:Director1 2023-04-01 2024-03-31 10187972 d:MotorVehicles 2023-04-01 2024-03-31 10187972 d:MotorVehicles 2024-03-31 10187972 d:MotorVehicles 2023-03-31 10187972 d:MotorVehicles d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10187972 d:FurnitureFittings 2023-04-01 2024-03-31 10187972 d:FurnitureFittings 2024-03-31 10187972 d:FurnitureFittings 2023-03-31 10187972 d:FurnitureFittings d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10187972 d:OwnedOrFreeholdAssets 2023-04-01 2024-03-31 10187972 d:CurrentFinancialInstruments 2024-03-31 10187972 d:CurrentFinancialInstruments 2023-03-31 10187972 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 10187972 d:CurrentFinancialInstruments d:WithinOneYear 2023-03-31 10187972 d:ShareCapital 2024-03-31 10187972 d:ShareCapital 2023-03-31 10187972 d:RetainedEarningsAccumulatedLosses 2024-03-31 10187972 d:RetainedEarningsAccumulatedLosses 2023-03-31 10187972 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2024-03-31 10187972 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-03-31 10187972 c:FRS102 2023-04-01 2024-03-31 10187972 c:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 10187972 c:FullAccounts 2023-04-01 2024-03-31 10187972 c:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10187972 2 2023-04-01 2024-03-31 10187972 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: 10187972









EYEDOCTOR.LONDON LTD







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

 
EYEDOCTOR.LONDON LTD
REGISTERED NUMBER: 10187972

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
53,914
67,387

  
53,914
67,387

Current assets
  

Debtors: amounts falling due within one year
 5 
108,498
86,068

Cash at bank and in hand
 6 
298,796
363,149

  
407,294
449,217

Creditors: amounts falling due within one year
 7 
(154,430)
(95,134)

Net current assets
  
 
 
252,864
 
 
354,083

Total assets less current liabilities
  
306,778
421,470

  

Net assets
  
306,778
421,470


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
306,678
421,370

  
306,778
421,470

Page 1

 
EYEDOCTOR.LONDON LTD
REGISTERED NUMBER: 10187972
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 27 November 2024.




................................................
Edward Lee
Director

The notes on pages 3 to 7 form part of these financial statements.
Page 2

 
EYEDOCTOR.LONDON LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

EyeDoctor.London Ltd is a private company limited by its share capital, incorporated in England and Wales. The principal activity of the company throughout the year was the provsion of specialist medical services.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 
EYEDOCTOR.LONDON LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line and reducing balance methods.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
reducing balance
Fixtures and fittings
-
25%
reducing balance and 3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.9

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Page 4

 
EYEDOCTOR.LONDON LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.10

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Total employees
2
2

Page 5

 
EYEDOCTOR.LONDON LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

4.


Tangible fixed assets





Motor vehicles
Fixtures and fittings
Total

£
£
£



Cost or valuation


At 1 April 2023
89,720
36,792
126,512


Additions
-
4,499
4,499



At 31 March 2024

89,720
41,291
131,011



Depreciation


At 1 April 2023
31,224
27,901
59,125


Charge for the year on owned assets
14,624
3,348
17,972



At 31 March 2024

45,848
31,249
77,097



Net book value



At 31 March 2024
43,872
10,042
53,914



At 31 March 2023
58,496
8,891
67,387


5.


Debtors

2024
2023
£
£

Trade debtors
89,576
83,976

Prepayments and accrued income
18,922
2,092

108,498
86,068



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
298,796
363,149

298,796
363,149


Page 6

 
EYEDOCTOR.LONDON LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
148,405
92,022

Other taxation and social security
271
172

Other creditors
2,664
-

Accruals and deferred income
3,090
2,940

154,430
95,134



8.


Financial instruments

2024
2023
£
£

Financial assets


Financial assets measured at fair value through profit or loss
298,796
363,149



Financial assets measured at fair value through profit or loss comprise cash at bank and in hand.


9.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £60,000 (2023 - £40,000). Contributions totalling £Nil (2023 - £Nil) were payable to the fund at the balance sheet date.


10.


Related party transactions

EyeDoctors.London Limited is a parent company, who owns 100% of the issued shares and in which directors, Edward and Rhiannon Lee, are directors and shareholders.
During the year transactions totalling £546,434 (2023 - £296,707) were made with this company. At the end of the year £Nil (2023 - £Nil) was outstanding.


11.


Controlling party

The Company is controlled by Eyedoctors.London Limited, a parent company, who owns 100% of the issued shares and in which directors, Edward and Rhiannon Lee, are directors and shareholders.
 
Page 7